Abstract
The human hepatitis B virus (HBV) is a member of the hepadnavirus family, which is compromised of DNA viruses that share structural and biological features. HBV infectivity is characterized by a marked hepatotropism, which is a prominent feature of hepadnaviruses. Although the majority of individuals infected with HBV resolve the primary infection and develop lasting immunity to subsequent infection, clinical studies have shown that 5–10% of individuals are chronically infected with the virus (Redeker, 1975). It has been estimated that there are over 250 million chronic HBV carriers worldwide (Rossner, 1992). A clinical consequence of chronic HBV infection is cirrhosis of the liver, which can lead to liver failure and death (Degroote et al., 1979). Furthermore, epidemiological studies have demonstrated that there is a strong association between hepatocellular carcinoma (HCC) and chronic HBV infection (Szmuness, 1978; Beasley et al., 1981). This association is supported by the following evidence: 1) there is a strong correlation in the geographical distribution of HCC and the occurence of chronic HBV infection, and 2) the hepatitis B surface antigen (HBsAg) is detected with a marked frequency in individuals with HCC. There is additional compelling evidence which correlates HBV with carcinogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonucci, T.K. and Rutter, W.J. (1989) Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner, J. Virol. 63, 579–583.
Aufiero, B. and Schneider, R.J. (1990) The hepatitis B virus X-gene trans-activates both RNA polymerase II and III promoters, EMBO J. 9, 497–504.
Avantaggiati, M.L., Natoli, G., Balsano, C, Chirillo, P., Artini, M., DeMarzio, E., Collepardo, D. and Levrero, M. (1993) The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements, Oncogene 8, 1567–1574.
Beasley, R.P., Lin, C.-C., Hwang, L.-Y. and Chien, C.-S. (1981) Hepatocellular carcinoma and hepatitis B virus, Lancet 2, 1129–1133.
Ben-Levy, R., Faktor, O., Berger, I. and Shaul, Y. (1989) Cellular factors that interact with the hepatitis B virus enhancer, Mol. Cell. Biol. 9, 1804–1809.
Brechot, G, Pourcel, G, Louis, A., Rain, B. and Tiollais, P. (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA in human hepatocellular carcinoma, Nature 286, 533.
Bulla, GA. and Siddiqui, A. (1988) The hepatitis B virus enhancer modulates transcription of the hepatitis B virus surface antigen gene from an internal location, J. Virol. 62, 1437–1441.
Buratowski, S., Sopta, M., Greenblatt, J. and Sharp, P.A. (1991) RNA polymerase II-associated proteins are required for a DNA conformation change in the transcription initiation complex, Proc. Natl. Acad. Sci. USA 88, 7509–7513.
Clayton, D.F., Harrelson, A.L. and Darnell, J.E. (1985) Dependence of liver- specific transcription on tissue organization, Mol. Cell. Biol. 5, 2623–2632.
Colgrove, R., Simon, G. and Ganem, D. (1989) Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication, J. Virology 63, 4019–4026.
Cross, J.G, Wen, P. and Rutter, W.J. (1993) Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases, Proc. Natl. Acad. Sci. USA 90, 8078–8082.
Degroote, J., Fevery, J. and Lepoutre, L. (1979) Long-term follow-up of chronic active hepatitis of moderate severity, Gut 19, 510–513
de Wet, J.R., Wood, K.V., Deluca, M., Helinski, D.R. and Subramani, S. (1987) Firefly luciferase gene: Structure and expression in mammalian cells, Mol.Cell. Biol. 7, 725–737.
Dikstein, R., Faktor, O., Ben-Levy, R. and Shaul, Y. (1990a) Functional organization of the hepatitis B virus enhancer, Mol. Cell. Biol. 10, 3683–3689.
Dikstein, R., Faktor, O. and Shaul, Y. (1990b) Hierarchic and cooperative binding of the rat liver nuclear protein C/EBP at the hepatitis B virus enhancer, Mol. Cell. Biol. 10, 4427–4430.
Edman, J.G, Gray, P., Valenzuela, P., Rall, L.B. and Rutter, W.J. (1980) Integration of hepatitis B virus sequences and their expression in a human hepatoma cell lin, Nature 286, 535.
Faktor, O. and Shaul, Y. (1990) The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax, Oncogene 5, 867–872.
Garcia, D.A., Natesan, S., Alexandre, G and Gilman, M.A. (1992) Functional interaction of nuclear factors EF-C, HNF-4, and RXRa with hepatitis B virus enhancer I, J. Virol. 67, 3940–3950.
Grueneberg, D.A., Natesan, S., Alexandre, C. and Gilman, M.Z. (1992) Human and drosophila homeodomain proteins that enhance the DNA binding activity of serum response factor, Science 257, 1089–1095.
Guo, W., Bell, K. and Ou, J.-H. (1991) Characterization of the hepatitis B virus enh I enhancer and X promoter complex, J. Virol. 65, 6686–6692.
Honigwachs, J. Faktor, O., Dikstein, R., Shaul, Y. and Laub, O. (1989) Liver- specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer, J. Virol. 63, 919–924.
Hu, K.-Q., Vierling, J.M. and Siddiqui, A. (1990) Trans-activation of HLA-DR gene by hepatitis B virus X gene product, Proc. Natl. Acad. Sci. USA 87, 7140–7144.
Hu, K.-Q. and Siddiqui, A. (1991) Regulation of the hepatitis B virus gene expression by the enhancer element I, Virology 181, 721–726.
Hu, K.-Q., Yu, C.-H. and Vierling, J.M. (1992) Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein, Proc. Natl. Acad. Sci. USA 89,11441–11445.
Huan, B. and Siddiqui, A (1992) Retinoid X receptor RXRa binds to and trans-activates the hepatitis B virus enhancer, Proc. Natl. Acad. Sci. USA 89, 9059–9063.
Jameel, S. and Siddiqui, A. (1986) The human hepatitis B virus enhancer requires trans-acting cellular factors for activity, Mol. Cell. Biol. 6, 710–715.
Jameel, S. Siddiqui, A., Maguire, H.R and Rao, K.V.S. (1990) Hepatitis B virus X protein produced in Escherichia coli is biologically functional, J. Virology 64,3963–3966.
Katayama, K., Hayashi, N., Sasaki, Y., Kasahara, A., Ueda, K., Fusamoto, H., Sato, N., Chisaka, O., Matsubara, K. and Takenobu, K. (1989) Detection of hepatitis B virus X gene protein and antibody in type B chronic liver disease, Gastroenterology 97, 990–998.
Kekule, A.S., Lauer, U., Weiss, L., Luber, G. and Hofschneider, P.H. (1993) Hepatitis B virus transactivator HBx uses a tumour promoter signaling pathway, Nature 361, 742–745.
Kim, C.-M., Koike, K., Saito, I., Miyamura, T. and Jay, G. (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice, Nature 351, 317–320.
Kwee, L., Lucito, R., Aufiero, B. and Schneider, R.J. (1992) Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters, J. Virology 66, 4382–4389.
Levrero, M., Jean-Jean, O., Balsano, C, Will, H. and Perricaudett, M. (1990) Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection, Virology 174, 299–304.
Lopez-Cabrera, M., Letovsky, J., Hu, K.-Q. and Siddiqui, A. (1990) Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: Transactivation and repression by CCAAT/enhancer binding protein, Proc. Natl. Acad. Sei USA 87, 5069–5073.
Lopez-Cabrera, M., Letovsky, J., Hu, K.-Q. and Siddiqui, A. (1991) Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus, Virology 183, 825–829.
Luber, B., Burgelt, E., Fromental, C, Kanno, M., Kanno, M. and Koch, W. (1991) Multiple simian virus 40 enhancer elements mediate the trans-activating function of the X protein of hepatitis B virus, Virology 184, 808–813.
Maguire, H.F., Hoeffler, J.P. and Siddiqui, A. (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions, Science 252, 842–844.
Mahe, Y., Mukaida, N., Kuno, K., Akiyama, M., Ikeda, N., Matsushima, K. and Murakami, S. (1991) Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/ enhancer-binding protein-like cis-elements, J. Biol. Chem. 266, 13759–13763.
Marion, P.L., Salazar, F.H., Alexander, J.J. and Robinson, W.S. (1980) Sate of hepatitis B viral DNA in a human hepatoma cell line, J. Virol. 33, 795.
Menzo, S., Clementi, M., Alfani, E., Bagnarelli, P., Iacovacci, S., Manzin, A., Dandri, M., Natoli, G., Levrero, M. and Carloni, G. (1993) Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product, Virology 196, 878–882.
Moriarty, A.M., Alexander, H. and Lerner, R.A. (1985) Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma, Science 227, 429–433.
Murakami, S., Cheong, J., Ohno, S., Matsushima, K. and Kaneko, S. (1994) Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways, Virology 199, 243–246.
Nakatake, H., Chisaka, O., Yamamoto, S., Matsubara, K. and Koshy, R. (1993) Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication, Virology 195, 305–314.
Natoli, G., Avantaggiati, M.L., Chirillo, P., Costanzo, A., Artini, M., Balsanoi, C. and Levrero, M. (1994) Induction of the DNA-binding activity of c-Jun/c-Fos heterodimers by the hepatitis B virus enhancer region, Mol. Cell. Biol. 14, 989–998.
Ostapchuk, P., Scheirly, G. and Hearing, P. (1989) Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region, Mol. Cell. Biol. 9, 2787–2797.
Patel, N., Jameel, S., Isom, H. and Siddiqui, A. (1989) Interactions between nuclear factors and the hepatitis B virus enhancer, J. Virol. 63, 5293–5301.
Raney, A.K. and McLachlan, A (1991) The biology of hepatitis B virus, in Molecular Biology of the Hepatitis B Virus, Mclachlan, A., E., CRC Press, Boca Raton, Florida, 1–38.
Redeker, A.G. (1975) Viral hepatitis: clinical aspects, Am. J. Med. Sci. 270, 9–16.
Roberts, S.G.E., Ha, I., Maldonado, E., Reinberg, D. and Green, M.R. (1993) Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation, Nature 363, 741–744.
Rossner, M.T. (1992) Review: Hepatitis B virus X-gene product: A promiscuous transcriptional activator, Journal of Medical Virology 36,101–117.
Seto, E., Benedict Yen, T.S., Matija Peterlin, B. and Ou, J.-H. (1988) Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein, Proc. Natl. Acad. Sci. USE 85, 8286–8290.
Shafritz, D.A., Shouval, D., Sherman, H., Hadziyannis, S.J. and Kew, M.C. (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma, N. Engl. J. Med. 305, 1067.
Shaul, Y., Rutter, W.J. and Laub, O. (1985) A human hepatitis B enhancer element, The EMBO J. 4, 427–430.
Siddiqui, A., Jameel, S. and Mapoles, J. (1987) Expression of the hepatitis B virus gene in mammalian cells, Proc. Natl. Acad. Sci. USA 84, 2513–2517.
Siddiqui, A., Gaynor, R., Srinivasan, A, Mapoles, J. and Wesley Farr, R. (1989) Trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein, Virology 169, 479–484.
Smith, D.B. and Johnson, K.S. (1988) Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase, Gene 67, 31–40.
Spandau, D.F. and Lee, C.-H. (1988) Trans-activation of viral enhancers by the hepatitis B virus X protein, J. Virology 62, 427–434.
Su, H. and Yee, J.-K. (1992) Regulation of hepatitis B virus gene expression by its two enhancers, Proc. Natl. Acad. Sci. USA 89, 2708–2712.
Szmuness, W. (1978) Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association, Prog. Med. Virol. 24, 40–69.
Tiollais, P., Pourcel C. and Dejean, A., (1985) The hepatitis B virus, Nature 317, 489–495.
Trujillo, M.A., Letovsky, J., Maguire, H.F., Lopez-Cabrera, M. and Siddiqui, A.(1991) Functional analysis of a liver-specific enhancer of the hepatitis B virus, Proc. Natl. Acad. Sci. USA 88, 3797–3801.
Twu, J.-S. and Schloemer, R.H. (1987) Transcriptional trans-activating function of hepatitis B virus, J. Virology 61, 3448–3453.
Twu, J.-S., Chu, K. and Robinson, W.S. (1989) Hepatitis B virus X gene activates kB-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1, Proc. Natl. Acad. Sci. USA 86, 5168–5172.
Van der Vliet, P.C. and Verrijzer, C.P. (1993) Bending of DNA by transcription factors, BioEssays 15, 25–32.
Vitvitski, L., Meyers, M.L., Sninsky, J.J., Berthillon, P., Chevalier, P., Sells, M.A., Acs, G. and Trepo, C. (1988) Expression of the X gene product of hepatitis B virus and WHV in infected livers and transfected 3T3 cells. Evidence for cross-reactivity and correlation with core/e gene expression. In Zuckerman, A.J. (ed.): “Viral Hepatitis and Liver Disease.” New York: Alan R. Liss Inc., pp. 341–344.
Vitvitski-Trepo, L., Kay, A., Pichoud, C, Chevallier, P., De-Dinechin, S., Shamoon, B.M., Mandart, E., Trepo, C. and Galibert, F. (1990) Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection, Hepatology 12, 1278–1283.
Yee, J.-K. (1989) A liver-specific enhancer in the core promoter region of human hepatitis B virus, Science 246, 658–661.
Yuh, C.-H. and Ting, L.-P. (1993) Differentiated liver cell specificity of the second enhancer of hepatitis B virus, J. Virol. 67, 142–149.
Zoulim, F., Saputelli, J. and Seeger, C. (1994) Woodchuck hepatitis virus X protein is required for viral infection in vivo, J. Virology 68, 2026–2030.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kosovsky, M.J., Maguire, H.F., Huan, B., Siddiqui, A. (1994). Liver-Specific Aspects of Hepatitis B Virus Gene Expression. In: Skouteris, G.G. (eds) Liver Carcinogenesis. NATO ASI Series, vol 88. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79215-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-79215-1_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79217-5
Online ISBN: 978-3-642-79215-1
eBook Packages: Springer Book Archive